Evidence map›Paper›PMID 38352326›Full record

ArticlebioRxiv : the preprint server for biology2024

3D Bioprinting of Collagen-based Microfluidics for Engineering Fully-biologic Tissue Systems.

Daniel J Shiwarski, Andrew R Hudson, Joshua W Tashman, Ezgi Bakirci, Samuel Moss, Brian D Coffin, Adam W Feinberg

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Daniel J ShiwarskiDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA.ORCID 0000-0001-6978-303X
Andrew R HudsonDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
Joshua W TashmanDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA.ORCID 0000-0001-8193-0039
Ezgi BakirciDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA.ORCID 0000-0002-4938-1540
Samuel MossDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA.ORCID 0000-0002-8471-5489
Brian D CoffinDepartment of Materials Science and Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA.ORCID 0000-0001-7256-8525
Adam W FeinbergDepartment of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA.ORCID 0000-0003-3338-5456
Carnegie Mellon University · USDivision of Materials Science and Engineering · AUUniversity of Pittsburgh · US

Funding

Development of a Collagen-based 3D Bioprinted Microfluidic Platform for Vascular Tissue Engineering and Disease ModelingR00HL155777 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHIWARSKI, DANIEL J · 2023 to 2025
$747k
Development of a Collagen-based 3D Bioprinted Microfluidic Platform for Vascular Tissue Engineering and Disease ModelingK99HL155777 · NHLBI · CARNEGIE-MELLON UNIVERSITY · PI SHIWARSKI, DANIEL J · 2021 to 2022
$222k
3D Printed Collagen Tracheal Scaffolds with Biomimetic MicrostructureF30HL154728 · NHLBI · CARNEGIE-MELLON UNIVERSITY · PI TASHMAN, JOSHUA · 2020 to 2022
$134k
NHLBI NIH HHS F30 HL154728NHLBI NIH HHS K99 HL155777NHLBI NIH HHS R00 HL155777
6 · The paper itself

Abstract

Microfluidic and organ-on-a-chip devices have improved the physiologic and translational relevance of in vitro systems in applications ranging from disease modeling to drug discovery and pharmacology. However, current manufacturing approaches have limitations in terms of materials used, non-native mechanical properties, patterning of extracellular matrix (ECM) and cells in 3D, and remodeling by cells into more complex tissues. We present a method to 3D bioprint ECM and cells into microfluidic collagen-based high-resolution internally perfusable scaffolds (CHIPS) that address these limitations, expand design complexity, and simplify fabrication. Additionally, CHIPS enable size-dependent diffusion of molecules out of perfusable channels into the surrounding device to support cell migration and remodeling, formation of capillary-like networks, and integration of secretory cell types to form a glucose-responsive, insulin-secreting pancreatic-like microphysiological system.

Identifiers

PMID38352326
PMCPMC10862740
OpenAlexW4391338873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.